Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
Public ClinicalTrials.gov record NCT05044819. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
Study identification
- NCT ID
- NCT05044819
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Jazz Pharmaceuticals
- Industry
- Enrollment
- 154 participants
Conditions and interventions
Interventions
- Cannabidiol Drug
Drug
Eligibility (public fields only)
- Age range
- 1 Year and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 6, 2021
- Primary completion
- Jul 31, 2027
- Completion
- Mar 30, 2028
- Last update posted
- Apr 21, 2026
2021 – 2028
United States locations
- U.S. sites
- 26
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Trial Site | Little Rock | Arkansas | 72758 | — |
| Clinical Trial Site | Downey | California | 90242 | — |
| Clinical Trial Site | Long Beach | California | 90806 | — |
| Clinical Trial Site | Sacramento | California | 95817 | — |
| Clinical Trial Site | Miami | Florida | 33136 | — |
| Clinical Trial Site | Miami | Florida | 33176 | — |
| Clinical Trial Site | Orlando | Florida | 32806 | — |
| Clinical Trial Site | Tampa | Florida | 33606 | — |
| Clinical Trial Site | Augusta | Georgia | 30912 | — |
| Clinical Trial Site | Wichita | Kansas | 67214 | — |
| Clinical Trial Site | Lexington | Kentucky | 40504 | — |
| Clinical Trial Site | Baltimore | Maryland | 21205 | — |
| Clinical Trial Site | Boston | Massachusetts | 02114 | — |
| Clinical Trial Site | New Brunswick | New Jersey | 08901 | — |
| Clinical Trial Site | New York | New York | 10016 | — |
| Clinical Trial Site | Charlotte | North Carolina | 28203 | — |
| Clinical Trial Site | Durham | North Carolina | 27708 | — |
| Clinical Trial Site | Cincinnati | Ohio | 45219 | — |
| Clinical Trial Site | Oklahoma City | Oklahoma | 73104 | — |
| Clinical Trial Site | Philadelphia | Pennsylvania | 19107 | — |
| Clinical Trial Site | Charleston | South Carolina | 29425 | — |
| Clinical Trial Site | Austin | Texas | 78758 | — |
| Clinical Trial Site | Dallas | Texas | 75251 | — |
| Clinical Trial Site | Houston | Texas | 77030 | — |
| Clinical Trial Site | Round Rock | Texas | 78681 | — |
| Clinical Trial Site | Winchester | Virginia | 22601 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05044819, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 21, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05044819 live on ClinicalTrials.gov.